Business

Moderna recently announced that the Food and Drug Administration (FDA) has postponed the approval of its respiratory syncytial virus (RSV) vaccine until the end of May. This unexpected delay was attributed to “administrative constraints” within the agency, causing some uncertainty regarding the timeline for the vaccine’s release. Initially, the FDA was set to make a
0 Comments
Mike Tyson’s highly anticipated return to the boxing ring to face off against Jake Paul this summer has already generated a significant buzz. The bout, scheduled for July 20 at AT&T Stadium in Arlington, Texas, is set to be streamed globally on Netflix, making it accessible to fans worldwide. With Tyson, a former heavyweight champion
0 Comments
The absence of a Marvel film at the start of the 2024 summer movie season is a noticeable change from previous years. Since 2008, Marvel Cinematic Universe films have typically kicked off the summer movie season, consistently bringing in substantial box office numbers. This year, Universal’s “The Fall Guy” took the spotlight for the first
0 Comments
Oddity Tech, a newly public Israeli cosmetics platform, has defied expectations in the beauty retail sector with its first-quarter results. The company, which utilizes artificial intelligence to develop products, reported earnings per share of 61 cents, adjusted, compared to the 49 cents that Wall Street was anticipating. Additionally, revenue for the quarter reached $211.63 million,
0 Comments
Former Starbucks CEO Howard Schultz recently commented on the coffee chain’s disappointing quarterly report, pointing out that the company’s U.S. stores need significant improvement to bounce back. Despite no longer holding an official position at Starbucks, Schultz identified a key factor contributing to the decline. He emphasized the need for enhancing the mobile order and
0 Comments
Wayfair, the online furniture retailer, recently announced its first quarter results, showcasing a decline in sales but a reduction in losses after implementing a significant workforce reduction at the beginning of the year. Despite the sales decline, Wayfair managed to surpass Wall Street’s expectations in terms of both revenue and loss per share. The company
0 Comments
Johnson & Johnson recently announced its plan to pay $6.5 billion over 25 years to resolve the majority of lawsuits in the United States alleging that its talc-based products led to ovarian cancer. This move comes in the wake of mounting legal and financial challenges faced by the company due to these claims. Despite maintaining
0 Comments
In a significant legal development, a federal judge in New Jersey dismissed the legal challenges posed by Johnson & Johnson and Bristol Myers Squibb against the Biden administration’s Medicare drug-price negotiations. This ruling confirms the constitutionality of the program and represents a victory for the White House in its ongoing battle against major drug manufacturers.
0 Comments